BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagashima S, Mendes MC, Camargo Martins AP, Borges NH, Godoy TM, Miggiolaro AFRDS, da Silva Dezidério F, Machado-Souza C, de Noronha L. Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief Report. Arterioscler Thromb Vasc Biol 2020;40:2404-7. [PMID: 32762443 DOI: 10.1161/ATVBAHA.120.314860] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Reference Citation Analysis]
2 Gille-johnson P, Kessler I, Tehrani S. Impaired Microvascular Function in Patients With Critical COVID-19. Critical Care Explorations 2022;4:e0643. [DOI: 10.1097/cce.0000000000000643] [Reference Citation Analysis]
3 Keikha R, Hashemi-Shahri SM, Jebali A. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur J Med Res 2021;26:75. [PMID: 34256840 DOI: 10.1186/s40001-021-00544-4] [Reference Citation Analysis]
4 Khandelwal G, Ray A, Sethi S, Harikrishnan HK, Khandelwal C, Sadasivam B. COVID-19 and thrombotic complications-the role of anticoagulants, antiplatelets and thrombolytics. J Family Med Prim Care 2021;10:3561-7. [PMID: 34934647 DOI: 10.4103/jfmpc.jfmpc_1297_20] [Reference Citation Analysis]
5 Liu LP, Lu L, Zhao QQ, Kou QJ, Jiang ZZ, Gui R, Luo YW, Zhao QY. Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning. Front Cell Dev Biol 2021;9:756340. [PMID: 34805165 DOI: 10.3389/fcell.2021.756340] [Reference Citation Analysis]
6 Nowroozpoor A, Bank M, Jafari D. Limb Ischemia due to Extensive Arterial Thrombosis in the Absence of Venous Occlusion as an Unusual Complication of Critical Illness from COVID-19. Case Rep Acute Med 2021;4:23-31. [DOI: 10.1159/000514291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Silva ACV, Machado-Junior PAB, Anizelli LB, Stocco RB, Moura LAZ, Motta Junior JDS, Blume GG. Pulmonary thromboembolism in conjunction with intracavitary thrombus caused by severe acute respiratory syndrome coronavirus-2 infection in a patient living with human immunodeficiency virus. Rev Soc Bras Med Trop 2021;54:e01572021. [PMID: 34105629 DOI: 10.1590/0037-8682-0157-2021] [Reference Citation Analysis]
8 Colling ME, Tourdot BE, Kanthi Y. Inflammation, Infection and Venous Thromboembolism. Circ Res 2021;128:2017-36. [PMID: 34110909 DOI: 10.1161/CIRCRESAHA.121.318225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yao S, Luo N, Liu J, Zha H, Ai Y, Luo J, Shi S, Wu K. Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19. J Inflamm Res 2021;14:4785-94. [PMID: 34584437 DOI: 10.2147/JIR.S330356] [Reference Citation Analysis]
10 Ergül E, Yılmaz AS, Öğütveren MM, Emlek N, Kostakoğlu U, Çetin M. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation. Int J Cardiovasc Imaging 2021. [PMID: 34286447 DOI: 10.1007/s10554-021-02356-3] [Reference Citation Analysis]
11 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Reference Citation Analysis]
12 Harahsheh Y, Ludewick H, Pavey W, Ho KM. Endothelial biomarkers of thrombosis in critically ill patients with acquired coagulopathy: a prospective cohort study. Biomark Med 2022. [PMID: 35583036 DOI: 10.2217/bmm-2021-0576] [Reference Citation Analysis]
13 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Fahmy OH, Daas FM, Salunkhe V, Petrey JL, Cosar EF, Ramirez J, Akca O. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit Care Explor 2021;3:e0427. [PMID: 34036278 DOI: 10.1097/CCE.0000000000000427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Stonoga ETS, de Almeida Lanzoni L, Rebutini PZ, Permegiani de Oliveira AL, Chiste JA, Fugaça CA, Prá DMM, Percicote AP, Rossoni A, Nogueira MB, de Noronha L, Raboni SM. Intrauterine Transmission of SARS-CoV-2. Emerg Infect Dis 2021;27:638-41. [PMID: 33185524 DOI: 10.3201/eid2702.203824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
16 Manolis AS, Manolis TA, Manolis AA, Papatheou D, Melita H. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management. J Cardiovasc Pharmacol Ther 2021;26:12-24. [PMID: 32924567 DOI: 10.1177/1074248420958973] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
17 Hannemann J, Balfanz P, Schwedhelm E, Hartmann B, Ule J, Müller-Wieland D, Dahl E, Dreher M, Marx N, Rainer Böger. Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. Sci Rep 2021;11:9895. [PMID: 33972591 DOI: 10.1038/s41598-021-89180-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Stenmark KR, Frid MG, Gerasimovskaya E, Zhang H, McCarthy MK, Thurman JM, Morrison TE. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement. Pulm Circ 2021;11:20458940211015799. [PMID: 34046161 DOI: 10.1177/20458940211015799] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Kumar N, Zuo Y, Yalavarthi S, Hunker KL, Knight JS, Kanthi Y, Obi AT, Ganesh SK. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism. Viruses 2021;13:2209. [PMID: 34835015 DOI: 10.3390/v13112209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Okoro EU. TNFα-Induced LDL Cholesterol Accumulation Involve Elevated LDLR Cell Surface Levels and SR-B1 Downregulation in Human Arterial Endothelial Cells. Int J Mol Sci 2021;22:6236. [PMID: 34207810 DOI: 10.3390/ijms22126236] [Reference Citation Analysis]
21 Sashindranath M, Nandurkar HH. Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19. Stroke 2021;52:1895-904. [PMID: 33794655 DOI: 10.1161/STROKEAHA.120.032711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
22 Stassi C, Mondello C, Baldino G, Cardia L, Asmundo A, Ventura Spagnolo E. An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review. Int J Mol Sci 2021;22:12024. [PMID: 34769454 DOI: 10.3390/ijms222112024] [Reference Citation Analysis]
23 Borges NH, Godoy TM, Pereira MRC, Stocco RB, Dias VMCH, Baena CP, Marques GL. Pulmonary Thromboembolism in a Young Patient with Asymptomatic COVID-19. Arq Bras Cardiol 2020;115:1205-7. [PMID: 33470327 DOI: 10.36660/abc.20200957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
25 Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Reference Citation Analysis]
26 Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies. Open Forum Infect Dis 2021;8:ofab065. [PMID: 33732753 DOI: 10.1093/ofid/ofab065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
27 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Reference Citation Analysis]
28 Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 2021. [PMID: 34373622 DOI: 10.1038/s41577-021-00588-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Beltrán-camacho L, Eslava-alcón S, Rojas-torres M, Sánchez-morillo D, Martinez-nicolás MP, Martín-bermejo V, de la Torre IG, Berrocoso E, Moreno JA, Moreno-luna R, Durán-ruiz MC. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00465-w] [Reference Citation Analysis]
30 Centa A, Fonseca AS, Ferreira SGDS, Azevedo MLV, Vaz de Paula CB, Nagashima S, Machado-Souza C, Miggiolaro AFRDS, Baena CP, de Noronha L, Cavalli LR. Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Am J Physiol Lung Cell Mol Physiol 2020. [PMID: 33651636 DOI: 10.1152/ajplung.00457.2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
31 Sayed Ahmed HA, Merrell E, Ismail M, Joudeh AI, Riley JB, Shawkat A, Habeb H, Darling E, Goweda RA, Shehata MH, Amin H, Nieman GF, Aiash H. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Fam Med Community Health 2021;9:e000741. [PMID: 33879541 DOI: 10.1136/fmch-2020-000741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bouchard BA, Colovos C, Lawson MA, Osborn ZT, Sackheim AM, Mould KJ, Janssen WJ, Cohen MJ, Majumdar D, Freeman K. Increased histone-DNA complexes and endothelial-dependent thrombin generation in severe COVID-19. Vascul Pharmacol 2021;142:106950. [PMID: 34871770 DOI: 10.1016/j.vph.2021.106950] [Reference Citation Analysis]
33 Ding J, Song B, Xie X, Li X, Chen Z, Wang Z, Pan L, Lan D, Meng R. Inflammation in Cerebral Venous Thrombosis. Front Immunol 2022;13:833490. [DOI: 10.3389/fimmu.2022.833490] [Reference Citation Analysis]
34 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
35 Cooke JP, Connor JH, Jain A. Acute and Chronic Cardiovascular Manifestations of COVID-19: Role for Endotheliopathy. Methodist Debakey Cardiovasc J 2021;17:53-62. [PMID: 34992723 DOI: 10.14797/mdcvj.1044] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Hartog N, Faber W, Frisch A, Bauss J, Bupp CP, Rajasekaran S, Prokop JW. SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Rev Proteomics 2021;18:105-18. [PMID: 33779460 DOI: 10.1080/14789450.2021.1908894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kordyukova LV, Shanko AV. COVID-19: Myths and Reality. Biochemistry (Mosc) 2021;86:800-17. [PMID: 34284707 DOI: 10.1134/S0006297921070026] [Reference Citation Analysis]
38 Liu H, Wang Z, Sun H, Teng T, Li Y, Zhou X, Yang Q. Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention. Front Cardiovasc Med 2020;7:599334. [PMID: 33537347 DOI: 10.3389/fcvm.2020.599334] [Reference Citation Analysis]
39 Paul O, Tao JQ, West E, Litzky L, Feldman M, Montone K, Rajapakse C, Bermudez C, Chatterjee S. Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome. Respir Res 2022;23:25. [PMID: 35144622 DOI: 10.1186/s12931-022-01944-8] [Reference Citation Analysis]
40 Zheng W, Huang X, Lai Y, Liu X, Jiang Y, Zhan S. Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2. Front Pharmacol 2021;12:631206. [PMID: 34177566 DOI: 10.3389/fphar.2021.631206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Chourasia M, Koppula PR, Battu A, Ouseph MM, Singh AK. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection. Molecules. 2021;26. [PMID: 33668085 DOI: 10.3390/molecules26051200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Omland T, Prebensen C, Jonassen C, Svensson M, Berdal JE, Seljeflot I, Myhre PL. Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19. Open Heart 2021;8:e001884. [PMID: 34933965 DOI: 10.1136/openhrt-2021-001884] [Reference Citation Analysis]
43 Kula BE, Clancy CJ, Hong Nguyen M, Schwartz IS. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Lancet Microbe 2021;2:e405-14. [PMID: 34189490 DOI: 10.1016/S2666-5247(21)00091-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
44 Zhou X, Cheng Z, Hu Y. COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management. J Pers Med 2021;11:1328. [PMID: 34945800 DOI: 10.3390/jpm11121328] [Reference Citation Analysis]
45 Azevedo MLV, Zanchettin AC, Vaz de Paula CB, Motta Júnior JDS, Malaquias MAS, Raboni SM, Neto PC, Zeni RC, Prokopenko A, Borges NH, Godoy TM, Benevides APK, de Souza DG, Baena CP, Machado-Souza C, de Noronha L. Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19. Front Immunol 2021;12:656350. [PMID: 33868301 DOI: 10.3389/fimmu.2021.656350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Rebutini PZ, Zanchettin AC, Stonoga ETS, Prá DMM, de Oliveira ALP, Dezidério FDS, Fonseca AS, Dagostini JCH, Hlatchuk EC, Furuie IN, Longo JDS, Cavalli BM, Dino CLT, Dias VMCH, Percicote AP, Nogueira MB, Raboni SM, de Carvalho NS, Machado-Souza C, de Noronha L. Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features. Front Immunol 2021;12:685919. [PMID: 34122449 DOI: 10.3389/fimmu.2021.685919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]